Apo(a) phenotyping and long-term prognosis for coronary artery disease

Clin Biochem. 2010 May;43(7-8):640-4. doi: 10.1016/j.clinbiochem.2010.01.013. Epub 2010 Feb 12.

Abstract

Objectives: Identify whether the plasma concentration of Lp(a), apo(a) size or a greater affinity for fibrin predict the likelihood of cardiac death, non-fatal myocardial infarction, unstable angina, the need for additional revascularization, and stroke (MACCE).

Design and methods: We analyzed the clinical prognosis of 68 patients with coronary artery disease included in a case-controlled study which evaluated Lp(a) concentration, apo(a) size, and Lp(a) fibrin-binding. Cohort was conducted over a median of 8 years. We used Kaplan-Meier survival tables to evaluate cardiovascular and cerebrovascular events in the follow-up period.

Results: Apo(a) isoforms of small size are predictors of MACCE. We find an association between Lp(a) concentration and apo(a) fibrin-binding with major adverse cardiovascular and cerebrovascular events, although without statistically significant results.

Conclusions: Small-sized apo(a) isoforms are an independent risk factor for MACCE in patients with coronary artery disease in follow-up. Lp(a) plasma concentration and apo(a) fibrin-binding were associated, although not significant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angina, Unstable / blood
  • Apolipoproteins A / blood*
  • Coronary Artery Disease / blood*
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Fibrin / metabolism
  • Humans
  • Lipoprotein(a) / blood
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction / blood
  • Myocardial Revascularization
  • Phenotype*
  • Prognosis
  • Protein Binding
  • Stroke / blood

Substances

  • Apolipoproteins A
  • Lipoprotein(a)
  • Fibrin